Clinical Trials Browser

Interventional × Has results × Solid Tumor × Clear all

NCT05322408 2025-11-05

HCW9218 in Select Advanced Solid Tumors

Phase 1 Completed

18 enrolled 17 charts

Other solid neoplasm

Solid Tumor

NCT03770494 2025-11-04

A Study of LY3405105 in Participants With Advanced Cancer

Phase 1 Terminated

54 enrolled 26 charts

Other solid neoplasm

Solid Tumor

NCT01239381 2025-09-30

Individualized Stereotactic Body Radiotherapy of Liver Metastases

Phase NA Completed

92 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT03195478 2025-09-15

A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors

Phase 1/2 Completed

37 enrolled 32 charts

Other solid neoplasm

Solid Tumor

NCT04455620 2025-07-02

BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors

Phase 1/2 Terminated

49 enrolled 19 charts

Other solid neoplasm

Solid Tumor

NCT04671901 2025-05-28

A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Phase 2 Terminated

2 enrolled 4 charts

Other solid neoplasm

Solid Tumor

NCT04827576 2025-05-08

ELEVATELung&UC

Phase 2 Terminated

106 enrolled 22 charts

Other solid neoplasm

Solid Tumor

NCT03994211 2024-10-26

Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With Cancer

Phase 1 Completed

25 enrolled 33 charts

Other solid neoplasm

Solid Tumor

NCT03834220 2024-02-07

Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)

Phase 2 Terminated

63 enrolled 18 charts

Other solid neoplasm

Solid Tumor

NCT04071756 2024-02-07

Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions

Phase 2 Terminated

8 enrolled 12 charts

Other solid neoplasm

Solid Tumor

NCT04365413 2023-12-14

OU-SCC-MSOT

Phase NA Completed

54 enrolled 9 charts

Other solid neoplasm

Solid Tumor

NCT02718911 2023-10-16

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Phase 1 Completed

72 enrolled 23 charts

Other solid neoplasm

Solid Tumor

NCT04122625 2023-06-12

SMARTPLUS-106

Phase 1/2 Completed

46 enrolled 36 charts

Other solid neoplasm

Solid Tumor

NCT02278250 2023-03-16

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Phase 1 Completed

97 enrolled 77 charts

Other solid neoplasm

Solid Tumor

NCT03894540 2022-09-13

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

Phase 1 Terminated

22 enrolled 27 charts

Other solid neoplasm

Solid Tumor

NCT04035473 2022-04-13

A Study to Determine the Bioequivalence of Oraxol in Cancer Patients Treated With Intravenous Paclitaxel

Phase 1 Completed

42 enrolled 21 charts

Other solid neoplasm

Solid Tumor

NCT03220854 2022-01-10

SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx

Phase 2 Completed

5 enrolled 12 charts

Other solid neoplasm

Solid Tumor

NCT01004861 2022-01-04

Safety Study of PLX108-01 in Patients With Solid Tumors

Phase 1 Completed

132 enrolled 28 charts

Other solid neoplasm

Solid Tumor

NCT03752177 2021-10-22

A Study of LY3415244 in Participants With Advanced Solid Tumors

Phase 1 Terminated

12 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT02423343 2021-09-09

A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma

Phase 1/2 Completed

41 enrolled 21 charts

GastrointestinalOther solid neoplasmThoracic

Solid Tumor

NCT03264092 2021-04-01

Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors.

Phase NA Terminated

55 enrolled 9 charts

Other solid neoplasm

Solid Tumor

NCT02132754 2021-01-28

MK-4166-001

Phase 1 Completed

116 enrolled 61 charts

Other solid neoplasm

Solid Tumor

NCT03961100 2020-09-07

A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers.

Phase 1 Completed

31 enrolled 14 charts

Other solid neoplasm

Solid Tumor

NCT02541604 2020-02-25

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors

Phase 1/2 Terminated

87 enrolled 41 charts

Other solid neoplasm

Solid Tumor

NCT03042910 2019-12-17

A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors

Phase 1 Completed

38 enrolled 24 charts

Other solid neoplasm

Solid Tumor

NCT02737072 2019-08-12

A Study of LY2510924 and Durvalumab in Participants With Solid Tumors

Phase 1 Terminated

9 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT02488330 2019-07-23

An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored Study

Phase 3 Completed

12 enrolled 8 charts

Other solid neoplasm

Solid Tumor

NCT02472977 2018-11-01

CXCessoR4

Phase 1/2 Terminated

61 enrolled 11 charts

Other solid neoplasm

Solid Tumor

NCT02490475 2017-05-17

A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors

Phase 1 Completed

19 enrolled 25 charts

Other solid neoplasm

Solid Tumor

NCT00467779 2016-08-26

Study of Cobimetinib in Participants With Solid Tumors

Phase 1 Completed

119 enrolled 63 charts

Other solid neoplasm

Solid Tumor

NCT01682135 2016-08-26

A Study in Participants With Advanced Solid Tumors

Phase 1 Completed

28 enrolled 15 charts

Other solid neoplasm

Solid Tumor

NCT01327313 2016-05-13

A Study of EMD525797 in Solid Tumor Patients in Japan

Phase 1 Completed

27 enrolled 34 charts

Other solid neoplasm

Solid Tumor

NCT00982657 2015-11-20

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Phase 2 Terminated

34 enrolled 10 charts

Other solid neoplasm

Solid Tumor

NCT02494596 2015-11-10

A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors

Phase 1 Completed

19 enrolled 16 charts

Other solid neoplasm

Solid Tumor

NCT01463982 2015-04-23

Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Phase 1 Completed

21 enrolled 10 charts

Other solid neoplasm

Solid Tumor